Phio Pharmaceuticals News - PHIO

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.1079 -1.09% 9.7521 9.9327 9.50 9.51 9.86 14:00:39
more quote information »

Recent News

Date Time Source Heading
1/10/202017:22EDGARCurrent Report Filing (8-k)
12/18/201907:30EDGARCurrent Report Filing (8-k)
12/13/201916:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/13/201908:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/06/201917:16EDGARAmended Current Report Filing (8-k/a)
11/22/201917:23EDGARProxy Statement (definitive) (def 14a)
11/20/201906:02EDGARCurrent Report Filing (8-k)
11/18/201917:24EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/18/201907:29EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/13/201917:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/12/201917:21EDGARCurrent Report Filing (8-k)
11/12/201907:45EDGARCurrent Report Filing (8-k)
11/12/201907:31EDGARQuarterly Report (10-q)
11/08/201917:20EDGARProxy Statement - Notice of Shareholders Meeting..
11/08/201917:12EDGARAmended Current Report Filing (8-k/a)
10/25/201917:26EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/25/201917:26EDGARCurrent Report Filing (8-k)
10/15/201917:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/11/201916:24EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/02/201918:04EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/02/201906:00EDGARNotice of Effectiveness (effect)
10/01/201918:41EDGARSecurities Registration Statement (s-1)
9/25/201917:07EDGARSecurities Registration Statement (s-1/a)
8/30/201917:29EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/30/201917:28EDGARSecurities Registration Statement (s-1)
8/30/201917:27EDGARProxy Statement (definitive) (def 14a)
8/15/201907:05PRNUSPhio Pharmaceuticals and Helmholtz Zentrum München to..
8/12/201917:11EDGARCurrent Report Filing (8-k)
8/12/201917:10PRNUSPhio Pharmaceuticals Reports Second Quarter 2019 Financial..
8/12/201917:01EDGARQuarterly Report (10-q)
8/12/201916:51EDGARProxy Statement - Notice of Shareholders Meeting..
8/09/201917:21EDGARCurrent Report Filing (8-k)
5/20/201907:05PRNUSPhio Pharmaceuticals to Present at Sachs Associates 5th..
5/14/201917:22PRNUSPhio Pharmaceuticals Reports First Quarter 2019 Financial..
5/14/201917:21EDGARCurrent Report Filing (8-k)
5/14/201917:18EDGARQuarterly Report (10-q)
5/09/201917:19EDGARStatement of Beneficial Ownership (sc 13d)
4/10/201907:05PRNUSPhio Pharmaceuticals Appoints Dr. John Barrett as Chief..
3/28/201907:05PRNUSPhio and Glycostem to Collaborate on Use of its sd-rxRNA®..
3/27/201917:23EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/27/201917:20PRNUSPhio Pharmaceuticals Reports Fourth Quarter and Year End..
3/27/201917:18EDGARCurrent Report Filing (8-k)
3/27/201917:13EDGARAnnual Report (10-k)
3/25/201907:05PRNUSPhio Pharmaceuticals to Present Poster on the Use of..
3/01/201909:25EDGARStatement of Changes in Beneficial Ownership (4)
2/19/201908:55EDGARStatement of Changes in Beneficial Ownership (4)
2/15/201917:01EDGARCurrent Report Filing (8-k)
2/15/201907:15PRNUSPhio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief..
2/14/201914:21EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201913:42EDGARAmended Statement of Ownership (sc 13g/a)
See more news about this stock »
Your Recent History
Phio Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200117 19:28:31